Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling-Reference-Cited by-同舟云学术

Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling

Published:2009-08 Issue:2 Volume:16 Page:115-125
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Gewinner Christina,Wang Zhigang C.,Richardson Andrea,Teruya-Feldstein Julie,Etemadmoghadam Dariush,Bowtell David,Barretina Jordi,Lin William M.,Rameh Lucia,Salmena Leonardo,Pandolfi Pier Paolo,Cantley Lewis C.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference49 articles.

1. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells;Auger;Cell,1989

2. Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene;Barnache;Oncogene,2006

3. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer;Bergamaschi;Genes Chromosomes Cancer,2006

4. Oncogene-induced senescence as an initial barrier in lymphoma development;Braig;Nature,2005

5. The phosphoinositide 3-kinase pathway;Cantley;Science,2002

Cited by 399 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1–mediated lysosomal exocytosis;Journal of Cell Biology;2024-08-09

2. Differential Abundance of DNA Damage Sensors and Innate Immune Signaling Proteins in Inositol Polyphosphate 4-Phosphatase Type II–Negative Triple-Negative Breast Cancer Classified by Immunotype;The American Journal of Pathology;2024-08

3. PTEN acts as a crucial inflammatory checkpoint controlling TLR9/IL-6 axis in B cells;iScience;2024-07

4. Mechanistic Characterization of De Novo Generation of Variable Number Tandem Repeats in Circular Plasmids during Site‐Directed Mutagenesis and Optimization for Coding Gene Application;Advanced Biology;2024-06-16

5. HER2/PI3K/AKT pathway in HER2-positive breast cancer: A review;Medicine;2024-06-14